Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Colman

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Neuro-Oncology|December 28, 2018
A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastomaHoward Colman
Neurosurgical Focus|December 1, 2022
Editorial. The Raman effect on intraoperative diagnosis of central nervous system tumorsHoward Colman
Neuro-Oncology|May 19, 2017
Toward more informative biomarker-based clinical trials in glioblastomaHoward Colman
Neurosurgical Focus|June 2, 2018
Editorial. Potential survival benefit of resection in butterfly glioblastomaHoward Colman
Continuum (Minneapolis, Minn.)|December 4, 2020
Adult GliomasHoward Colman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Future directions in glioblastoma therapyHoward Colman
Archives of Neurology|July 16, 2008
Molecular predictors in glioblastoma: toward personalized therapyHoward Colman, Ken Aldape
Oncology (Williston Park, N.Y.)|January 22, 2013
Medulloblastoma: molecular classifications and prognostic associationsDennis C Shrieve, Howard Colman
Cancer Treatment and Research|December 4, 2014
Glioma biology and molecular markersAdam L Cohen, Howard Colman
Current Problems in Cancer|May 27, 2008
Brain tumor stem cellsErik Sulman, Ken Aldape, Howard Colman
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Neuro-Oncology|December 28, 2018
A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastomaHoward Colman
Neurosurgical Focus|December 1, 2022
Editorial. The Raman effect on intraoperative diagnosis of central nervous system tumorsHoward Colman
Neuro-Oncology|May 19, 2017
Toward more informative biomarker-based clinical trials in glioblastomaHoward Colman
Neurosurgical Focus|June 2, 2018
Editorial. Potential survival benefit of resection in butterfly glioblastomaHoward Colman
Continuum (Minneapolis, Minn.)|December 4, 2020
Adult GliomasHoward Colman
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Future directions in glioblastoma therapyHoward Colman
Archives of Neurology|July 16, 2008
Molecular predictors in glioblastoma: toward personalized therapyHoward Colman, Ken Aldape
Oncology (Williston Park, N.Y.)|January 22, 2013
Medulloblastoma: molecular classifications and prognostic associationsDennis C Shrieve, Howard Colman
Cancer Treatment and Research|December 4, 2014
Glioma biology and molecular markersAdam L Cohen, Howard Colman
Current Problems in Cancer|May 27, 2008
Brain tumor stem cellsErik Sulman, Ken Aldape, Howard Colman
Pageof 16